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Abstract
The Sec pathway plays a prominent role in protein export and membrane insertion, including the secretion of major
bacterial virulence determinants. The accessory Sec constituent SecDF has been proposed to contribute to protein export.
Deletion of Staphylococcus aureus secDF has previously been shown to reduce resistance, to alter cell separation, and to
change the expression of certain virulence factors. To analyse the impact of the secDF deletion in S. aureus on protein
secretion, a quantitative secretome analysis was performed. Numerous Sec signal containing proteins involved in virulence
were found to be decreased in the supernatant of the secDF mutant. However, two Sec-dependent hydrolases were
increased in comparison to the wild type, suggesting additional indirect, regulatory effects to occur upon deletion of secDF.
Adhesion, invasion, and cytotoxicity of the secDF mutant were reduced in human umbilical vein endothelial cells. Virulence
was significantly reduced using a Galleria mellonella insect model. Altogether, SecDF is a promising therapeutic target for
controlling S. aureus infections.
Citation: Quiblier C, Seidl K, Roschitzki B, Zinkernagel AS, Berger-Ba¨chi B, et al. (2013) Secretome Analysis Defines the Major Role of SecDF in Staphylococcus
aureus Virulence. PLoS ONE 8(5): e63513. doi:10.1371/journal.pone.0063513
Editor: Michael Otto, National Institutes of Health, United States of America
Received February 13, 2013; Accepted April 2, 2013; Published May 3, 2013
Copyright:  2013 Quiblier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the Gottfried und Julia Bangerter-Rhyner-Stiftung to CQ and by grants of the Foundation for Research at the Medical
Faculty, University of Zurich and Matching Funds of the Clinical Trials Center, University Hospital Zurich to KS. The research leading to these results has received
funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement nu 241446 (project ANTIRESDEV). The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: msenn@imm.uzh.ch
Introduction
The Gram-positive pathogen Staphylococcus aureus is one of the
leading causes of nosocomial infections [1]. Due to its acquisition
of various resistance genes treatment of S. aureus infections have
become increasingly difficult. Furthermore, the prevalence of
methicillin-resistant S. aureus (MRSA) has been increasing in recent
years. This has resulted in an alarming rise of community-
associated (CA-) MRSA infections in immunocompetent individ-
uals [2,3,4]. In addition to its adaptive response to antibiotics [5],
the success of S. aureus is based upon its huge array of virulence
factors [6] helping S. aureus to avoid host immunity. These
virulence factors have to be exported across the cytoplasmic
membrane to reach their destined location: the membrane, the cell
wall or the extracellular space. The main transport system is the
Sec translocase, which is conserved in all three kingdoms of life
[7,8]. Currently, the Sec pathway is best described in the Gram-
negative bacterium Escherichia coli (as reviewed in [9,10]). The
translocase consists of i) the heterotrimeric complex SecYEG,
which forms a hydrophilic channel through the cytoplasmic
membrane; ii) the motor protein SecA, an ATPase; and iii) the
heterotrimeric complex SecDF-YajC. Proteins containing an N-
terminal Sec signal peptide (SP) or a hydrophobic transmembrane
segment are targeted to the translocase and transported through
the channel in an unfolded state. For secreted proteins or
membrane proteins with large hydrophilic loops, the driving
energy is provided by the cycling of SecA, whereas ribosome-
bound nascent chains are targeted mainly by inner membrane
proteins [11] and are co-translationally exported powered by the
translating ribosome. Small membrane proteins can also be
inserted by YidC in a Sec-independent manner [12]. The auxiliary
complex SecDF-YajC was shown to associate with SecYEG [13]
as well as with YidC and is therefore believed to act as the linking
molecule between SecYEG and YidC during Sec-dependent
membrane protein insertion [12]. The integral membrane protein
YajC was found to co-crystallize with the well-known E. coli
multidrug exporter AcrB [14], which belongs to the resistance-
nodulation-cell division (RND) superfamily. Deletion of YajC only
showed a weak phenotype and its exact function is still unknown
[15,16].
SecDF also belongs to the RND superfamily and possesses the
typical twelve transmembrane (TM) domains with two extra-
cytoplasmic loops between TM1-2 and TM7-8, respectively [17].
Recently, Tsukazaki et al. resolved the crystal structure of the
membrane protein SecDF of Thermus thermophilus [18]. Two
conformations for the head subdomain P1 are observed, that
seem to occur upon rotation by 120u [18]. Furthermore the P1
head was shown to interact with an unfolded preprotein, thereby
preventing the substrate from backsliding and enhancing the
translocation. This ATP-independent step in the later stage of
protein translocation is driven by the proton motive force (PMF).
Two conserved charged residues Asp519 and Arg247 are crucial
for SecDF activity in E. coli and point mutations of the
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corresponding amino acids in T. thermophilus abolish ion channel
activity [18].
In S. aureus, SecA and SecY have been shown to be essential
[19,20,21]. Deletion of the non-essential secG leads to changes in
the exoproteome, which are enhanced in a secG-secY2 double
mutant [7]. SecY2 together with SecA2 belong to the accessory
Sec pathway, which at present is known to export only one
substrate, the serine-rich adhesin for platelets protein (SraP) [22].
However, virulence of the secG and secY2 single mutants and the
secG-secY2 double mutant in mice is comparable to the parental
strain [7].
We previously reported a S. aureus secDF mutant to have a
pleiotropic phenotype influencing not only protein secretion, but
also transcription and regulatory processes [23]. Resistance
towards b-lactam and glycopeptide antibiotics was reduced.
Furthermore, cell division was impaired and autolysis increased
[23]. To determine the role of SecDF in the secretion of virulence
factors and to assess its importance for pathogenesis, we performed
a secretome analysis using isobaric tags for relative and absolute
quantitation (iTRAQ) with subsequent LC-MS/MS. Major
virulence determinants involved in adhesion to host proteins and
cells, as well as in evasion of the host immune system were found to
be decreased in the exoproteome of the secDF mutant. Important
steps for establishing an infection were shown to be deficient in vitro
in the secDF mutant in both methicillin sensitive and resistant S.
aureus strains. Furthermore, secDF virulence was significantly
reduced in a Galleria mellonella infection model.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. If not mentioned otherwise bacterial cultures were grown
in Luria Bertani (LB) broth (Becton Dickinson, Difco Laboratories,
Franklin Lakes (NJ), USA) at 37 uC. Bacterial cultures were grown
under constant shaking and with a liquid-to-air ratio of 1:5 to
assure good aeration. Media were supplemented with 50 mg/ml
kanamycin (Sigma-Aldrich, St. Louis (MO), USA) or 10 mg/ml
erythromycin (Sigma-Aldrich, St. Louis (MO), USA) when
appropriate.
Sample preparation for secretome analysis
Strains were cultured until late exponential phase, which was
shown to correspond to OD600 1 in an earlier study [23] and
centrifuged at 4 uC for 5 min. The supernatant (SN) was filtered
(0.22 mM PES filter, Techno Plastic Products AG, Trasadingen,
Switzerland) and mini EDTA-free complete protease inhibitors
tablets (Roche, Rotkreuz, Switzerland) were added. For normal-
ization purposes 500 pM enhanced GFP (Ams Biotechnology Ltd,
Abingdon, UK) was added. The SN was concentrated by
trichloroacetic acid (TCA) precipitation and washed twice with
ice cold (220 uC) acetone. The pellet was resuspended in 0.5 M
triethylammonium bicarbonate pH 8.5 (Sigma-Aldrich, St. Louis,
USA) 0.5 mM tris(2-carboxyethyl)phosphine hydrochloride
(TCEP, Sigma-Aldrich, St. Louis (MO), USA). Protein concen-
tration was measured with the Quant-iTTM protein assay kit (Life
Technologies, Invitrogen, Carlsbad (CA), USA).
Proteins were digested and labelled according to the iTRAQ
protocol (AB Sciex, Concord, Canada). Briefly, 75 mg protein were
denatured with 0.1% SDS and reduced with 5 mM TCEP.
10 mM methyl methanethiosulfonate (MMTS) was used as a
cysteine blocking reagent. Protein samples were digested with
trypsin (Promega, Fitchburg (WI), USA) for 14.5 h at 37 uC and
subsequently labelled with a 4-plex-iTRAQ Reagent for 1.5 h at
room temperature. Phosphoric acid was added to stop the reaction
and samples were combined into a fresh Eppendorf tube. Peptides
were fractioned by strong cation exchange (SCX). Solvent A
(7 mM KH2PO4, 25% acetonitrile (ACN), pH 2.7) was added to
the sample and loaded onto a polysulfoethyl A column
(20062.1 mm, 5 mm, 200 A˚, PolyLC) of the analytical HPLC
(LC1100, Agilent Technologies, Santa Clara (CA), USA). Peptides
were eluted with an increasing gradient of solvent B (7 mM
KH2PO4, 0.5 M KCl, 25% ACN, pH 2.7) 10–50 min, 0–30%
solvent B; 40–60 min, 30–100% solvent B) and pooled into 12
fractions according to the chromatogram. Peptides were concen-
trated with the SpeedVacH (Eppendorf, Hamburg, Germany),
redissolved in 3% ACN, 0.1% trifluoroacetic acid and desalted
using ZipTips C18 (Merck Millipore, Billerica (MA), USA). After a
further vacuum concentration step the peptides were dissolved in
3% ACN, 0.1% formic acid (FA).
Mass spectrometry
Dissolved samples were injected into an Eksigent-nano-HPLC
system (Eksigent Technologies, Dublin (CA), USA) by an auto
sampler and separated on a self-made reverse-phase tip column
(200 mm6150 mm) packed with C18 material (3 mm, 200 A˚, AG,
Bischoff GmbH, Leonberg, Germany). The column was equili-
brated with 99% solvent A (1% ACN, 0.2% FA in water) and 1%
solvent B (0.2% FA in ACN). Peptides were eluted using the
following gradient: 0–3 min; 1–5% B, 3–57 min; 5–35% B, 57–
63 min; 35–50% B and 63–70 min; 50–99% B, at a flow rate of
0.7 ml/min. High accuracy mass spectra were acquired with an
AB Sciex 5600 (AB Sciex, Concord, Canada) in the mass range of
400–1250 m/z. Up to 40 data dependent MS/MS were recorded
in high sensitivity mode of the most intense ions with charge state
2+, 3+ and 4+ using collision induced dissociation. Target ions
already selected for MS/MS were dynamically excluded for 90 s
after tree accuracies. After data collection, the peak lists were
generated and analyzed using ProteinPilotTM 4.0 (AB Sciex,
Concord, Canada). Data was searched against a SwissProt
database (released January 2011). The following search parame-
ters were used: Trypsin digestion, modifications of MMTS labelled
cysteine, 4-plex-iTRAQ modifications of free amines at the N-
termini and of lysine, and 4-plex-iTRAQ modifications of tyrosine.
Biological modifications and single amino acid exchanges were
also included in the search. No normalization for iTRAQ ratios,
such as BIAS correction, was applied, as normalization was
performed by the addition of extrinsic GFP. The peptides without
any 4-plex-iTRAQ label at the N-terminus or at a lysine were
excluded from the analysis. The ProteinPilot cut-off score used was
1.3, which corresponds to a confidence limit of 95%. In total four
biological replicates were analyzed in two independent iTRAQ
experiments. The statistical analysis was assessed by the Student’s t
test.
SDS-PAGE and Western blot
The SN was collected using the secretome sample preparation
method and concentrated with Amicon Ultra-15 centrifugal filter
devices (MWCO 10 kDa Merck Millipore, Billerica (MA), USA).
Ten to 20 mg of protein were separated by SDS (10–15%)
polyacrylamide gel electrophoresis (PAGE) and blotted onto
polyvinylidene fluoride (PVDF) membrane (Immobilon-P, Merck
Millipore, Billerica (MA), USA). Blocking and detection were
performed in phosphate buffered saline (PBS) pH 7.4 (CHIPS,
FnBPA) or in low salt buffer (0.154 M NaCl, 9 mM TRIS, 0.1%
Tween) pH 7.4 (Eap, LytM, SceD and SEA) as described in [23].
The following primary antibodies were used: Mouse anti-CHIPS
antibody (Abcam, Cambridge, UK) 1:1’000, rabbit anti-Eap
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antibody (Abcam, Cambridge, UK) 1:5’000, rabbit anti-FnBPA
antibody (Abnova, Taipei City, Taiwan) 1:2’500, rabbit anti-LytM
antibody (obtained from T. Msadek [24]) 1:50’000, rabbit anti-
SceD antibody (obtained from S. Foster [25]) 1:10’000 and rabbit
anti-SEA antibody (Abcam, Cambridge, UK) 1:1’000. For
detection of the primary antibodies either horseradish peroxi-
dase-(HRP-) goat anti-rabbit IgG (1:10’000, Jackson ImmunoR-
esearch, West Grove (PA), USA) or HRP-goat anti-mouse IgG
(1:5’000, Jackson ImmunoResearch, West Grove (PA), USA) were
used.
Fibrinogen- and fibronectin-binding assay
The binding assay was adapted from O’Neill et al. [26]. Shortly,
100 ml two-fold dilutions of human fibrinogen (Merck, Calbio-
chem, Darmstadt, Germany) in 20 mM sodium citrate-HCl,
pH 7.4 or human fibronectin (Merck, Calbiochem, Darmstadt,
Germany) in PBS pH 7.4 were dispensed in flat-bottom 96-well
Nunclon plates and incubated overnight at 4 uC. Following three
PBS wash steps, the plates were blocked in 2 mg/ml bovine serum
albumin (BSA, Thermo Scientific, Acros Organics, Geel, Belgium)
in PBS for 2 h at 37 uC. Wells were washed three times in PBS. In
the meantime bacterial cultures were grown to OD600 1, washed
twice in PBS and adjusted to OD600 1 in PBS corresponding to
,108 cells/ml. Hundred ml of bacterial suspension was added per
well (107 CFU/well), including a negative control (PBS) and
incubated for 2 h at 37 uC. After repeated PBS washing steps, the
cells were fixed with 25% formaldehyde (Applichem, Darmstadt,
Germany), washed once with PBS and stained for 5 min in 0.5%
crystal violet. Residual dye was removed with distilled water
(dH2O) and plates were air-dried. The crystal violet stained cells
were dissolved in 5% acetic acid and the absorbance measured at
570 nm. The experiment was performed with three technical and
biological replicates, except for the positive control strain Cowan I
in the Newman fibronectin binding assay, which was only
performed with three technical replicates.
Tissue culture
Human umbilical vein endothelial cells (HUVECs) were
purchased from Clonetics (Lonza, Basel, Switzerland) and
maintained as previously described in M199 medium supplement-
ed with antibiotics (penicillin 100 U/ml, streptomycin 100 mg/ml),
glutamine at 2 mM, and 20% foetal calf serum, at 37 uC in a
humidified 5% CO2 atmosphere until they reached confluency
[27]. One day before assays were performed, HUVECs were
seeded at a density of 56104 cells/well into 48-well plates that
were coated with 10 mg/ml fibronectin. Cells were used up to
passage three.
Bacterial adherence and invasion to HUVECs
The capacity of the various strains to invade HUVECs was
determined by the lysostaphin protection assay using conditions
used for the MTT assays (see below) as previously described [28].
Adherence and invasion were expressed as % adherent and
invading cells per well at the time point of measurement.
Adherence and invasion of CHE482 were set to 100% for each
run. Each experiment was performed in duplicate in three
independent assays.
MTT assay
The ability of S. aureus to induce damage in HUVECs was
assessed using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide) assay. MTT is reduced by living cells to
insoluble purple MTT formazan crystals using succinate, and the
pyridine nucleotide cofactors, NADH and NADPH as substrates
[29]. MTT production is therefore inversely related to cell death.
MTT reduction results in a yellow to blue color change that can be
quantified by measuring the absorbance at OD570 [30]. MTT
assays were performed as previously described with some
modifications [31]. Briefly, wells containing HUVECs were rinsed
twice with warm HBSS prior inoculation to remove medium
containing antibiotics. The bacterial strains were grown overnight
on sheep blood agar, resuspended in invasion medium (1%
albumin and 25 mM HEPES, pH 7.3 in M199 without serum or
Table 1. Strains and plasmids used in this study.
Strains Properties Ref.
S. aureus
CHE482 CC45, ST45, SCCmecN1, blaZ (pBla), Fa
r, Mcr, Sxr, Tmr [51,53]
Cowan I NCTC8530, septic arthritis isolate ATCC12598
CQ66 Newman DsecDF [23]
CQ85 Newman pCN34, Kmr [23]
CQ87 Newman DsecDF pCN34, Kmr [23]
CQ89 Newman DsecDF pCQ27, Kmr [23]
CQ92 CHE482 pCN34, Kmr This study
CQ93 ME305 pCN34, Emr, Far, Kmr, Mcr, Sxr, Tmr This study
CQ94 ME305 pCQ27, Emr, Far, Kmr, Mcr, Sxr, Tmr This study
ME305 CHE482 DsecDF::bursa aurealis, Emr, Far, Mcr, Sxr, Tmr [54]
Newman Clinical isolate (ATCC 25904), rsbU+ [83]
Plasmids
pCN34 S. aureus-E. coli shuttle vector, pT181-cop-wt repC aphA-3 ColE1, Kmr, called pEmpty in this study [84]
pCQ27 pCN34 derivative carrying secDF with its endogenous promoter, Kmr, called pSecDF in this study [23]
Abbreviations are as follows: Emr, erythromycin resistant; Far, fusidic acid resistant; Kmr, kanamycin resistant; Mcr, methicillin resistant; Sxr, sulfomethoxazole resistant;
Tmr, tobramycin resistant.
doi:10.1371/journal.pone.0063513.t001
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antibiotics) to McFarland 0.5 (,56107 cells/ml), sonicated and
diluted to the indicated multiplicity of infection (MOIs) [32,33,34].
Initial inocula were confirmed by serial fold dilution and plating
on sheep blood agar. After 1 h or 3 h incubation at 37 uC in 5%
CO2, respectively, the number of CFUs per well was determined
to monitor growth. Then, the medium was aspirated, wells were
washed with HBSS and 400 ml of fresh complete M199 medium
containing 10 mg/ml lysostaphin was added [28,33,35]. After a
total incubation time of 22 h at 37 uC in 5% CO2, 100 ml of
5 mg/ml MTT in HBSS were added to each well. 2 h later, the
medium was removed and 150 ml of 0.04 M HCl in absolute
isopropanol were added to solubilize the dye. Uninfected control
wells which underwent the same washes were processed in parallel
and served as negative control. Wells that only contained medium
were used as background correction. Absorbance of 100 ml of the
solution was measured at 570 nm. Specific cytotoxicity was
calculated using the following formula: 1-(OD570 experimental
well/OD570 control well). Each experiment was performed in
triplicate in at least three independent assays.
Galleria mellonella virulence assay
To study the in vivo pathogenicity an invertebrate infection
model was used as previously described by Peleg et al. [36]. Last
instar larval stage G. mellonella were purchased at HRH Fishing
Hebeisen, Zurich, Switzerland and stored at 4 uC until further use.
Cells were grown until exponential phase (OD600 0.5), washed
twice in PBS and resuspended therein. Ten ml of bacterial
suspension, corresponding to 106 CFUs, were injected into the last
left proleg with a repetitive dispensing Tridak Stepper (Intertronic,
Oxfordshire, UK) containing a 1 ml syringe with a 26-gauge
needle. Thirty larvae were infected per strain. A control group was
inoculated with 10 ml of PBS to assure the larvae were healthy and
that death did not occur due to the needle prick or stress. Larvae
were incubated at 37 uC and examined every 24 h for survival;
they were considered dead when no movement occurred in
response to touch. Additional larvae were inoculated separately to
measure the bacterial burden which was monitored after 24, 48
and 72 hours. After incubating the larvae at 220uC, they were
disinfected in 70% ethanol and rinsed with dH2O. The larvae
were homogenized with the TissueLyser (Qiagen, Hombrechtikon,
Switzerland) in 2-ml screw cap tubes containing a 5 mm stainless
steel bead (Qiagen, Hombrechtikon, Switzerland) and 1 ml PBS,
shaking for 10 min at 30 s21. Appropriate dilutions were plated on
LB agar containing 50 mg/ml kanamycin to minimize growth of
the normal flora of the larvae. Three independent experiments
were pooled and analysed by log rank test. The survival-curves
were plotted using the Kaplan-Meier method.
Results
Deletion of secDF leads to an altered exoproteome
To determine the extent of the extracellular proteome affected
by deletion of secDF, a quantitative secretome analysis was
performed for the S. aureus wild type strain Newman and its
mutant strain Newman DsecDF using iTRAQ. The SNs were
collected during late exponential phase, where we found strongest
SecDF expression (data not shown). Samples of four biological
replicates were prepared for LC-MS/MS as described in materials
and methods.
A total of 230 S. aureus proteins were quantified and their
putative localization was determined with different bioinformatics
tools (Table 2, Table S1). Thirty-eight proteins had a predicted SP
[37], 34 thereof were predicted Sec-type SPs [38]. These included
seven cell wall proteins containing the LPXTG cell wall retention
motif (SpA, SdrE, ClfA, IsdA, FnBPA, ClfB) [39,40] or LysM
domains (Sle1/Aaa) [41]. In Newman DsecDF, in comparison to
the wild type Newman, the extracellular levels of 27 proteins were
altered significantly by at least two fold increase (two proteins) or
two fold decrease (25 proteins); 21 of these proteins contained a
Sec-type SP (Figure 1). Of the six remaining proteins, three were
membrane proteins; OatA and the LytR-CpsA-Psr proteins
NWMN_0925 (SA0908) and MsrR [42,43]. Furthermore, the
SP containing, but Sec-independent enterotoxin A (SEA) and the
delta hemolysin (Hld) were identified.
According to their function the majority of the proteins were
classified into three groups: i) Proteins with adhesive properties
(ClfA, ClfB, Coa, Emp, Efb/Fib, FnBPA, Eap/Map, SpA) [44,45];
ii) proteins which are involved in immune evasion (CHIPS, ClfA,
Efb, FLIPr, Eap, OatA, Sbi, SpA, SCIN, SEA, SspB) [46,47] and
iii) autolytic proteins (IsaA, LytM, SceD, SsaA) [25,48,49]. The
autolysin LytM and the lytic transglycosylase SceD were the only
proteins found to be significantly increased in the secretome of
Newman DsecDF. Furthermore, several proteases were decreased
in Newman DsecDF, such as SspB, SspA and ScpA, whereof the
amounts of SspB and ScpA were significantly reduced.
Peptides of the N-terminal region of the glycerol ester hydrolase
Geh were identified and found to be reduced in Newman DsecDF.
Because one of the four prophages in strain Newman is located in
the Geh gene geh, leading to a truncated and inactive enzyme [50],
this finding is not phenotypically relevant in the strain Newman
background. Nonetheless, in other S. aureus strain backgrounds,
deletion of secDF can be expected to reduce lipase activity.
Complementation of the altered virulence factor
expression in the mutant strain Newman DsecDF and
verification of its phenotype in a second strain
background
To validate and further highlight the role of SecDF in S. aureus,
a different, methicillin resistant strain background was included in
the following confirmatory experiments. The low level methicillin
resistant strain CHE482 represents a CA-MRSA [51,52,53]; its
corresponding secDF mutant CHE482 DsecDF carries a transposon
at position 1029 bp leading to a non-functional SecDF protein
[54]. To complement the deletion of secDF, the plasmid pSecDF
(pCQ27) containing secDF with its endogenous promoter from
strain Newman was introduced into the mutant strains Newman
DsecDF and CHE482 DsecDF, yielding Newman DsecDF pSecDF
and CHE482 DsecDF pSecDF, respectively. The empty vector
pEmpty (pCN34) was introduced into the wild type strains
Newman and CHE482 and the secDF mutants Newman DsecDF
and CHE482 DsecDF to ensure no additional effects were caused
by the plasmid (Table 1).
To confirm the secretomics results, Western blot analysis of the
SN from these strains were performed for selected proteins found
to be altered in the secretome of Newman DsecDF. Specific
antibodies were used for the Sec-dependent proteins CHIPS, Eap,
FnBPA, LytM and SceD, as well as the Sec-independent SEA.
As expected, the SN of Newman DsecDF showed reduced
protein amounts of CHIPS, FnBPA, Eap and SEA and increased
amounts of LytM and SceD in comparison to the wild type and
the complemented mutant (Figure 2A). This phenotype was
validated and confirmed for CHIPS, FnBPA and SceD in strain
background CHE482 (Figure 2B).
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Decreased adherence of the secDF mutant to attached
human fibrinogen, fibronectin and endothelial cells
To establish an infection, the ability of S. aureus to adhere to host
proteins and cells is essential and permits the bacteria to invade
into the cells as shown previously for S. aureus [55]. Our
secretomics screen revealed several factors belonging to the
microbial surface components recognizing adhesive matrix mol-
ecules (MSCRAMM) or the secretable expanded repertoire
adhesive molecules (SERAM) to be reduced in Newman DsecDF
(Table 3). Therefore, binding of the secDF mutants to immobilized
human fibrinogen and fibronectin, respectively, was studied in vitro.
Ninety-six-well-plates were coated with various concentrations of
human fibrinogen and fibronectin, respectively. Bacteria were
allowed to adhere to the coated wells, washed, fixed and coloured
with crystal violet as described in materials and methods.
Binding of Newman DsecDF pEmpty to fibrinogen was reduced
by up to 50% in comparison to the wild type strain Newman
pEmpty and the complemented mutant Newman DsecDF pSecDF
Figure 1. Differential extracellular protein amounts in Newman DsecDF in comparison to the wild type Newman. Proteins identified to
be significantly and more than two-fold changed in Newman DsecDF compared to the wild type Newman. The mean values of four independent
experiments are shown with their standard deviation given, except for NWMN_1019 and ScpA, which were only found in two biological replicates.
Proteins are colour coded according to the following categories: N-terminal Sec signal peptide (SP), LPXTG-motif, adhesive properties (MSCRAMM
and SERAM), immune evasive properties, autolytic properties and membrane proteins. Proteins confirmed below by Western blot analysis are
highlighted in bold. *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0063513.g001
Table 2. Localization of identified proteins based on different bioinformatics tools [85,86,87] and Sibbald et al. [38].
Localization Proteins (%) Sec signal peptide Remarks
Cytoplasm 172 (74.8)
Membrane 9 (3.9)
Lipoprotein 2 (0.9)
Cell wall 7 (3.0) 7 6 covalently attached by LPXTG motif
Extracellular 31 (13.5) 27 6 non-covalently bound to the cell wall
Unknown 9 (3.9)
Total 230 (100)
doi:10.1371/journal.pone.0063513.t002
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(Figure 3A). In CHE482, binding of CHE482 DsecDF pEmpty was
reduced at low concentrations of fibrinogen, but not at concen-
trations above 2 mg/ml (Figure 3B). This phenotype was restored
in both strains by the complementing plasmid pSecDF.
Fibronectin binding proteins are not anchored to the cell wall in
strain Newman due to a point mutation leading to an early stop
codon and truncated proteins without sortase motif [56].
Therefore, strain Cowan I was used as a functional control in
the binding assay of Newman to human fibronectin [56]. As
expected, the binding capacity of strain Newman pEmpty to
fibronectin was up to ten times lower as compared to strain Cowan
I (Figure 3A). However, deletion of secDF further reduced binding
Figure 2. Complementation of SecDF-dependent changes. Western blot analysis of extracellular proteins in the SN of two different strain
backgrounds. (A) Newman harbouring empty plasmid pEmpty (pCN34), the mutant strain Newman DsecDF harbouring empty plasmid pEmpty
(pCN34) and the complemented mutant Newman DsecDF mutant harbouring plasmid pSecDF (pCQ27) containing the secDF gene with its
endogenous promoter. (B) CHE482, the mutant strain CHE482 DsecDF and the complemented mutant strain CHE482 DsecDF harbouring plasmid
pSecDF (pCQ27). Specific antibodies against CHIPS, FnBPA, Eap, LytM, SceD and SEA were used. Truncated FnBPA in Newman runs below the 70 kDa
marker band. Putative degradation bands of FnBPA have been observed before [56,80,81,82] and are indicated by a ring. Additional protein bands
due to unspecific binding to protein A or Sbi are indicated by an asterisk.
doi:10.1371/journal.pone.0063513.g002
Table 3. Adhesins, which were reduced in the SN of Newman DsecDF.
Proteins Binding to human fibrinogen Binding to human fibronectin Ref.
MSCRAMM ClfA x [88]
ClfB x [89]
FnBPA x x [80,90]
SpA
SERAM Coa x [91]
Eap x x [92]
Emp x x [93]
Efb x [94]
doi:10.1371/journal.pone.0063513.t003
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to fibronectin in the Newman background and was partially
restored by the complementing plasmid. In CHE482, the secDF
mutant showed a similar concentration dependent phenotype for
fibronectin as for fibrinogen, with the CHE482 DsecDF pEmpty
displaying a reduced binding at lower fibronectin concentrations
(Figure 3B). These findings suggest the presence of additional
fibrinogen and fibronectin binding proteins in the CHE482
background, possibly on mobile genetic elements, which reduce
the effect of a secDF deletion on adhesion to fibrinogen and
fibronectin.
In a next step, we investigated whether the secDF deletion would
also affect adherence to host endothelial cells (human umbilical
vein endothelial cells, HUVECs). Because of the point mutation in
the FnBPs of strain Newman mentioned above, this strain has
been previously shown to be weakly adherent to HUVECs [56].
Therefore, we used the secDF mutant of strain CHE482 to test
adherence and found significantly reduced adherence as compared
to the wild type strain (Figure 4A). This effect was restored in the
complemented mutant CHE482 DsecDF pSecDF. In accordance
with the previous findings [56] adherence by strain Newman was
only 12.766.6% of strain CH482.
secDF inactivation leads to reduced cytotoxicity
Many of the virulence factors produced by S. aureus destroy host
tissue to allow dissemination. Thus, we analyzed the ability of the
secDF mutant to damage endothelial cells using a previously
Figure 3. Impact of SecDF on fibrinogen and fibronectin binding. Binding properties of Newman and CHE482 strain sets to immobilized
human fibrinogen and fibronectin was assessed as described in materials and methods. (A) Newman pEmpty, Newman DsecDF pEmpty and the
complemented mutant Newman DsecDF pSecDF. FnBPs in the Newman background are truncated due to a point mutation leading to a stop codon
before the sortase motif, which is required for cell wall anchoring, and therefore are secreted [56]. Hence, Cowan I was used as a functional control
strain in the fibronectin binding assay. (B) CHE482 harbouring empty plasmid pEmpty (pCN34), the mutant strain CHE482 DsecDF harbouring empty
plasmid pEmpty (pCN34) and the complemented mutant CHE482 DsecDF pSecDF. Mean of three independent experiments are shown with their
standard deviation.
doi:10.1371/journal.pone.0063513.g003
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published MTT assay [31]. This assay measures MTT reduction
by living cells and is inversely related to cell death. We previously
showed that MTT reduction by HUVECs internalized S. aureus is
negligible [31]. To evaluate cytotoxicity of strain Newman, we
used similar conditions as previously described using a MOI of 50
[33]. In this assay, endothelial cells are infected with bacteria for
3 h. Then, extracellular bacteria are killed and damage is assessed
24 h after the addition of the bacteria. Strain Newman did not
induce substantial damage under these conditions (15.8610.9%
damage) and was not suited to study the effect of secDF inactivation
Figure 4. Adhesion, cytotoxicity and invasion in HUVECs. Interactions of Newman and the CHE482 strain set the wild type CHE482, CHE482
DsecDF and the complemented mutant CHE482 DsecDF pSecDF with HUVECs. (A) Effect of secDF inactivation in the CHE482 background on adhesion.
(B) Growth in invasion medium. The arrow indicates the time point at which extracellular bacteria are lysed. (C) Inoculum dependent cytotoxicity of
wild-type strains as determined by the MTT assay. (D) Effect of secDF inactivation in the CHE482 background on cytotoxicity as determined by the
MTT assay. (E) Effect of secDF inactivation in the CHE482 background on invasion. ***, P,0.0001.
doi:10.1371/journal.pone.0063513.g004
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on S. aureus cytotoxicity. We therefore decided to use strain
CHE482, which caused a significant higher damage (69615%)
and the corresponding secDF mutant. However, CHE482 DsecDF
exhibited a growth defect in invasion medium during the 3 h
invasion step (Figure 4B). We therefore decreased the invasion
time to 1 h, while bacteria appeared to be in the lag-phase
showing no measurable difference in OD600 or CFUs between the
strains (Figure 4B). Because these conditions have not been
previously used to study S. aureus-induced endothelial cell damage,
it was essential to identify an optimal MOI. Figure 4C shows the
increasing cytotoxicity of strain CHE482 with increasing MOIs
ranging from 25 to 2500. Again, damage induced by strain
Newman under these conditions was very low. Using an MOI of
2500, we found that secDF inactivation in strain CHE482 led to a
substantial reduction in cytotoxicity (Figure 4D). This phenotype
could be complemented using strain CHE482 DsecDF pSecDF,
which contains the secDF locus on a plasmid. To determine
whether the reduced cytotoxicity of CHE482 DsecDF was due to a
reduction in endothelial cell invasion, invasion was assessed under
similar conditions as for the MTT assay. The mutant strain
CHE482 DsecDF exhibited significantly reduced invasion as
compared to the wild type strain (Figure 4E). This effect was
restored in the complemented mutant CHE482 DsecDF pSecDF.
In accordance with the low adherence and cytotoxicity of strain
Newman, invasion was only 1.661.0% of strain CHE482.
Inactivation of secDF leads to reduced pathogenicity in
an insect infection model
To assess the influence of SecDF on virulence, Newman strains
were injected into last instar larval stage G. mellonella and survival
of the larvae was monitored over time. Resuspension buffer for
bacterial cultures was used as a negative control. The dimensions
and masses of larvae in one group spanned representative and
comparable ranges, as preparatory experiments did not show any
correlation concerning larval weight and survival (data not shown).
Pathogenicity of Newman DsecDF pEmpty in G. mellonella was
significantly reduced (P,0.001) in comparison to the wild type
Newman pEmpty and the complemented mutant Newman DsecDF
pSecDF (Figure 5A). To ensure that the attenuated virulence was
not due to growth deficiencies of the mutant, the bacterial burden
per larvae was measured after 24, 48 and 72 hours. Variation of
CFU per larvae was rather high within the strains, for instance at
24 hours post infection (hpi) the wild type showed a bacterial
burden ranging from 1.546105 to 4.626107 (Figure 5B). Howev-
er, all three strains were able to multiply in the larvae within a
similar range during the first 48 hpi, with CFUs being even higher
in the secDF mutant after 72 hpi than in the wild type and the
complemented mutant. The different peak time points of CFU/
larvae in the secDF mutant (72 hpi) compared to the wild type or
complemented mutant (48 hpi) was not reflected in the survival of
G. mellonella, further indicating a strongly reduced virulence in
Newman DsecDF pEmpty, that was not compensated by increased
CFU numbers.
Discussion
Secretion of numerous virulence factors such as adhesins,
proteases, autolysins and toxins rely on a functional Sec secretion
system for the export across the cytoplasmic membrane [38]. So
far, most studies of the Sec machinery were performed in the
Gram-negative and Gram-positive model organisms E. coli and B.
subtilis, respectively. This study focused on the impact of the
auxiliary SecDF protein on virulence in the human pathogen
S. aureus by analysing the exoproteome of Newman DsecDF in a
gel-free approach, followed by in vitro and in vivo virulence studies.
Our secretomics results were in good agreement with previous
data [23]. A relatively high number of cytoplasmic proteins was
found in the SN, which has already been observed by other
research groups and in different microorganisms [57,58,59,60].
This occurrence has been assigned to cell wall turnover,
proteolytic processing, shedding, natural lysis and lysis due to
handling [61,62,63]. Nevertheless, we identified several new
Figure 5. G. mellonella virulence assay. (A) Pathogenicity of
Newman pEmpty, Newman DsecDF pEmpty and Newman DsecDF
pSecDF in G. mellonella. Larvae were monitored every 24 hours. PBS
was used as negative control. Three independent experiments were
pooled and plotted as Kaplan-Meier survival curve, P,0.001. (B)
Bacterial burden per (live) larvae was measured in triplicates 24, 48
and 72 h post infection (hpi). The symbols triangle, square, diamond
and line correspond to replicates I, II, III and the average, Ø, respectively.
The inoculum (CFU/larvae) is shown at time point zero.
doi:10.1371/journal.pone.0063513.g005
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proteins to be influenced by SecDF. This was confirmed by
Western blot analysis and could be complemented for the proteins
CHIPS, Eap, FnBPA, LytM and SEA.
Eight out of 11 proteins, identified in both the previously
characterized S. aureus RN4220 secG mutant [7] and Newman
DsecDF, showed a similar trend and were found to be reduced in
both mutants in comparison to the wild types (Sle1, Geh, Hlb,
Hla, HlgB, HlgC, NWMN_1927 and YfnI). Three proteins (IsaA,
Spa and SsaA) were found to be increased in the secG mutant, but
reduced in Newman DsecDF. Different methods, sampling time
points and strain backgrounds could have contributed to those
divergent findings. Another possibility is that SecDF is required for
a subset of proteins deviating from the ones that require SecG. In
addition, since they have different functions in the Sec pathway,
the absence of SecG or SecDF might lead to only partially
overlapping phenotypes.
Two Sec-dependent proteins were found to be increased in
Newman DsecDF; the autolysin LytM and the transglycosylase
SceD. Kouwen et al. had observed, that a B. subtilis LipA hyper-
producing strain could export the normally Sec-dependent LipA,
which also contains a potential Tat RR-SP via both Tat pathways
[64]. S. aureus LytM and SceD do not contain a potential Tat RR-
SP; whether they are secreted by another transport system in
Newman DsecDF remains to be determined.
In the secG mutant only one Sec-independent protein was
identified to be reduced; YfnI/LtaS [7], which was also found
reduced in Newman DsecDF (Table S1). Additionally, the two Sec-
independent proteins Hld and SEA were found to be significantly
reduced upon deletion of secDF. Hld belongs to the phenol-soluble
modulins and has recently been shown to be exported by the ABC
transporter Pmt [65]. The fact that the amounts of certain Sec-
independent proteins were changed in both the secG and the secDF
mutant, points towards indirect effects caused by the deletion of
these Sec translocase constituents. Slightly reduced levels for the
regulatory and Hld-encoding mRNA RNAIII have been shown
previously in Newman DsecDF [23]. Because RNAIII transcription
is regulated by the two-component system accessory gene
regulator (agr) the reduction of RNAIII levels suggest that agr is
indirectly affected by secDF deletion [23,66]. Clearly, more work is
required to confirm this hypothesis and to determine whether
other regulatory processes are influenced directly or indirectly by
the absence of SecDF.
Secretome analysis showed decreased SpA levels in Newman
DsecDF consistent with a previously reported reduction of spa
transcription [23]. In contrast, previous and present Western blot
analysis showed similar levels of full-length SpA in the wild type
and Newman DsecDF. A possible explanation for these seemingly
contradictory findings could be the reduced amounts of SspA
protease in the Newman DsecDF (Table S1). SspA is the main
player of SpA degradation [67]. Higher SpA and SspA levels in
the wild type would lead to more SpA degradation fragments,
which can be detected by secretome analysis and increase the total
protein amounts attributed to SpA, but would be too small to be
detected by Western blot analysis. Whether this is the case still
needs to be investigated.
Several well known virulence factors playing a central role
during the initial steps of an infection were decreased in Newman
DsecDF. These changes led to reduced binding to the two
important human host factors fibrinogen and fibronectin in vitro.
Although the effect of the secDF deletion on the adhesion intensity
varied between the two strains tested and was smaller in CHE482,
we also found significantly reduced adhesion of CHE482 DsecDF
to HUVECs. This was accompanied by a significantly decreased
invasion and must be attributed to the sum of impaired factors in
the mutant and the multitude of additional host matrix factors S.
aureus can bind to. In this study, the two important invasion factors
Eap and FnBPA were found to be reduced [68,69]. While the
receptor of Eap is still unknown, the FnBPs bind via the bridging
factor fibronectin to the host receptor integrins a5b1, which is
sufficient to induce the uptake of staphylococci [68]. Thus, the low
cytotoxicity in HUVECs displayed by CHE482 DsecDF must be
assumed to be at least partially caused by its defective adhesion
and invasion, in addition to a reduced production of toxins. The
decreased levels of numerous virulence factors and the reduced
cytotoxicity, indicative for virulence in mice and rabbits
[33,70,71], suggested the virulence of the secDF mutant to be
attenuated. We therefore determined the pathogenicity of New-
man DsecDF pEmpty in the invertebrate model host G. mellonella,
sharing several features of the innate immune response with
mammalians [72,73]. A positive correlation has been shown
between the pathogenicity of microorganisms in insects and in
mice [74,75] and in recent years this model has been increasingly
used for assessing the virulence of S. aureus [36,76,77,78,79]. As
expected, virulence was significantly attenuated in Newman
DsecDF pEmtpy. The similar bacterial load per larvae indicated
that Newman DsecDF pEmtpy has the ability to multiply as well as
the parent strain and that the generally diminished virulence factor
expression Newman DsecDF pEmtpy is the cause for its reduced
virulence.
Taken together, our data provide new insights on the relevance
of SecDF in S. aureus pathogenicity. We showed that deletion of
secDF affects an important part of the extracellular proteome
leading to reduced adhesion, invasion and cytotoxicity, as well as
reduced virulence in G. mellonella. Because both MSSA and MRSA
secDF mutants are less resistant to well established antibiotics [23],
SecDF is an interesting target for the development of novel
antimicrobial substances.
Supporting Information
Table S1 Proteins found in the supernatant of S. aureus Newman
and Newman DsecDF and their predicted localization.
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